B cell therapy maker Be Bio stops hemophilia trial

June 16, 2026 03:05 PM EDTUpdated 03:22 PM R&DCell/Gene Tx B cell ther­a­py mak­er Be Bio stops he­mo­phil­ia tri­al Lei Lei Wu News Reporter Be Bio­phar­ma dis­closed in a fed­er­al clin­i­cal tri­als list­ing that it has ter­mi­nat­ed its study of a he­mo­phil­ia B ther­a­py made … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER